NCT06689878 Mobile Cognitive Behavioral Therapy for Stroke
| NCT ID | NCT06689878 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Weill Medical College of Cornell University |
| Condition | Anxiety |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2025-02-25 |
| Primary Completion | 2028-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2025-02-25 with a primary completion date of 2028-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to assess the feasibility and acceptability of "MAYA", a mobile cognitive behavioral therapy app for anxiety and mood disorders, in adults who have had a stroke.
Eligibility Criteria
Inclusion Criteria: * Age 40-79 * Presence of clinically-significant anxiety and/or depression (as determined by an eligibility evaluation) * Stroke that occurred 1 month or more prior to study initiation * Capacity to provide consent * No greater than mild cognitive difficulties based on an eligibility evaluation conducted as part of the study * If taking medication for depression and/or anxiety, must be on a stable dose for a minimum of 8 weeks prior to study initiation * Ability to use iPhone or iPad independently * Home internet access * Willingness to participate in the full study duration. Exclusion Criteria: * Aphasia of moderate or greater severity (as determined during an eligibility evaluation) * Non-fluency in English * History of a bipolar or psychotic disorder * Current alcohol or substance use disorder * Active suicidal ideation * Current engagement in psychotherapy is not grounds for exclusion unless the individual's psychotherapy is primarily focused on CBT * Severe depression and/or anxiety based on the initial evaluation and clinical judgment of the study doctor, which warrants a higher level of care and/or immediate referral to psychiatric services * Any other clinical or medical reason in the study doctor's initial screening evaluation that suggests the study is not appropriate for the participant
Contact & Investigator
Abhishek Jaywant, PhD
PRINCIPAL INVESTIGATOR
Weill Medical College of Cornell University
Frequently Asked Questions
Who can join the NCT06689878 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 79 Years, studying Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06689878 currently recruiting?
Yes, NCT06689878 is actively recruiting participants. Contact the research team at abj2006@med.cornell.edu for enrollment information.
Where is the NCT06689878 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT06689878 clinical trial?
NCT06689878 is sponsored by Weill Medical College of Cornell University. The principal investigator is Abhishek Jaywant, PhD at Weill Medical College of Cornell University. The trial plans to enroll 10 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.